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Title: Heterogeneity in Cochrane and non-Cochrane meta-analyses in orthodontics  
Abstract 
Objectives: Heterogeneity describes the percentage of variability across the study effects that can 
be attributed to between-study differences in a meta-analysis. The aim of this project was to 
explore the magnitude of heterogeneity in Cochrane and non-Cochrane meta-analyses in 
orthodontic research and to identify possible associations between heterogeneity (I2) and a number 
of study characteristics including number of studies, type of outcome and type of analysis. 
Methods: The contents of five major orthodontic journals and the Cochrane Database of Systematic 
Reviews were electronically searched from January 2000 to December 2017 to identify Systematic 
Reviews (SRs) with at least one meta-analysis. Included records were screened for reporting of I2 
classified into four categories: 0%, 1- 29%, 30- 59%, 60- 100%. Associations between I2 and review- 
level and synthesis- level characteristics were tested. Univariable and multivariable mixed effects 
ordinal logistic regression was used to identify significant predictors for statistical heterogeneity. 
Results: A total of 72 SRs comprising 391 meta-analyses were included with the majority based on 
non-Cochrane reviews (n=54, 75%). Overall, 125 meta-analyses (32%) reported heterogeneity 
explained by chance (I2= 0%), whereas high values of I2 (~60-100%) were seen in 152 syntheses 
(39%). In the multivariable analysis, inclusion of each additional study within the synthesis 
presented 20% higher odds for substantial/considerable heterogeneity compared to lower 
heterogeneity categories (OR= 1.20; 95%CIs: 1.09, 1.31; p<0.001). Use of fixed effect analysis (OR= 
0.25; 95%CIs: 0.12, 0.55; p=0.001) was associated with significantly lower odds. Cochrane versus 
non-Cochrane meta-analyses were not associated with higher odds for substantial/considerable 
heterogeneity (OR= 2.81; 95%CIs: 0.53, 14.91; p=0.22).  
Conclusions: Substantial statistical heterogeneity is present within a considerable number of 
orthodontic meta-analyses. Further efforts should be made to improve understanding of decisions 
to undertake meta-analyses and selection of studies eligible for inclusion.  
Clinical Significance: The consistency of meta-analyses could be improved with more careful 
consideration of individual study characteristics. Reduced heterogeneity in meta-analyses will 
ensue more solid evidence based decisions for clinical practice    
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Introduction 
Recent years has seen an increase in publication of systematic reviews (SRs) and meta-analyses in 
biomedical research as they are considered by healthcare professionals the most effective and 
transparent approach to provide a synthesis of research and clinical evidence and guide decision 
making in practice [1–3]. Notwithstanding this, these have attracted criticism both related to 
excessive publication of overlapping and barren reviews, as well as concerns in relation to the 
quality and yield associated with many of these [4–6].  
A meta-analysis uses a mathematical approach to combine the results from individual studies with 
regard to a research question of interest in order to obtain an overall estimate of the treatment 
effect [7]. However, due to the fact that individual studies may differ in terms of settings, 
populations, interventions, outcomes or design, it may be possible that this lack of homogeneity or 
heterogeneity may render the findings inconsistent. Inconsistency refers to the presence of 
variation across the results of individual studies greater than that anticipated by chance [8]. 
Presence of unexplained inconsistency is an important reason for downgrading the quality of the 
evidence from meta-analyses [9,10]. 
Assessment of heterogeneity involves both clinical and statistical aspects. Clinical heterogeneity 
refers to a priori identification of differences in population settings, interventions or variations in 
treatment outcomes and may be detected upon examination of the eligibility criteria for the 
population under study [11,12]. Statistical heterogeneity can be inspected either visually or through 
statistical tests. Visual inspection involves examination of the forest plots and assessment of 
variation in the point estimates of the included studies as well as the degree of overlap of the 
associated confidence intervals [13]. Statistical heterogeneity may be confirmed through statistical 
tests, the most known of which are the Q- statistic also referred to as the chi-squared test and the 
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I2 statistic [14,15]. A statistically significant chi-squared test (i.e. p<0.1) may indicate important 
variation in individual study estimates; however, false negative results cannot be excluded 
especially when few studies are included in the meta-analysis [13]. The I2 statistic is considered a 
more straightforward measure to quantify heterogeneity describing the percentage variability in 
the point estimates that are attributed to heterogeneity due to between study differences [14].  
The Cochrane Collaboration has suggested the use of four categories when interpreting 
heterogeneity based on I2 as follows: 0-40% unimportant heterogeneity, 30-60% moderate, 50-90% 
substantial and 75- 100% considerable heterogeneity. The degree of overlap between these 
categories represents the subjectivity in interpreting the magnitude of heterogeneity [16]. Empirical 
evidence based on Medline and Cochrane databases has indicated that moderate to substantial 
statistical heterogeneity has been identified in up to 39% of meta-analyses in medicine, depending 
on the type of outcome assessed, while I2 has been shown to increase as the number of studies 
included in the meta-analysis increases for continuous outcomes [17].  
The degree of statistical heterogeneity might constitute an indicator of inappropriate synthesis of 
conceptually different studies. Statistical heterogeneity may arise as a result of clinical or 
methodological differences between studies. This pertains to differences related to the 
participants, interventions and outcomes, or differences in study design or risk of bias within 
studies. Where the variation in treatment effect is greater than that anticipated to arise due to 
chance, the presence of increased levels of heterogeneity is suspected [10]. This in turn may 
compromise conclusions drawn from meta-analysis of heterogeneous studies, with attendant 
effects on the translation of the findings to clinical practice in terms of clinical decision making, or 
the generalizability of the results [18]. As such, careful consideration of study characteristics prior 
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to possible inclusion within a planned meta-analysis is important with clear delineation of eligibility 
criteria based ideally on a pre-planned protocol.   
To our knowledge, there has been no similar attempt to quantify the magnitude of heterogeneity 
within meta-analyses in dentistry. The primary objective of the present study was therefore to 
record and quantify the extent of statistical heterogeneity (based on I-squared; I2) in Cochrane and 
non- Cochrane meta-analyses in the major dental specialty of orthodontics. In addition, we aimed 
to identify possible associations between heterogeneity and a number of study characteristics 
including year of publication, funding, type and significance of outcome, type of mathematical 
analysis followed and number of studies included within the syntheses.  
Materials and Methods 
The contents of five major orthodontic journals, namely the American Journal of Orthodontics and 
Dentofacial Orthopedics (AJODO), Angle Orthodontist (Angle), European Journal of Orthodontics 
(EJO), Journal of Orthodontics (JO), and Orthodontics and Craniofacial Research (OCR), as well as 
orthodontic topics covered in the Cochrane Database of Systematic Reviews (CDSR) were 
electronically searched from January 2000 to December 2017. The selection of journals was based 
on the relative frequency of systematic reviews (SRs) published within them. On initial screening, 
articles were considered potentially eligible if they included the terms “systematic review” or 
“meta-analysis” in the title or the abstract. Relevant articles (SRs) were finally included after full 
text evaluation, when at least one mathematical synthesis was undertaken with associated report 
of the degree of heterogeneity based on I2 statistic.  
The selection of articles was carried out by two authors (DK, IM) and data was extracted on pre-
specified standardized forms by one author (DK) covering the following information: 
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- Article level: journal, type of review (interventional/epidemiologic), continent of authorship, 
number of authors, year of publication, involvement of a statistician/methodologist, number of 
syntheses per study and funding. 
- Meta-analysis (synthesis) level: magnitude of heterogeneity (I2%), point estimate along with 
confidence interval (95% CIs), design of included studies, number of studies within syntheses, type 
of outcome (binary/continuous), type of analysis (random effects, fixed effects), significance of 
meta-analysis outcome (significant, non-significant). Standard errors (SE) were calculated for each 
summary outcome from point estimates and 95%CIs. Heterogeneity (I2%) was further classified to 
four non-overlapping categories: 0%, 1- 29%, 30- 59%, 60- 100% based on previous research [17]. 
Consultation with one author (NP) was performed when uncertainty existed.  
Descriptive statistics in relation to the characteristics of the included studies were undertaken at 
review level and based on publication type (Cochrane, non-Cochrane). Cross-tabulations and 
associations between level of heterogeneity and synthesis type were applied.  Chi-squared and 
Fisher’s exact tests were performed where appropriate. Furthermore, a scatterplot was used to 
graphically present the relationship between number of studies included within the synthesis and 
I2. Mixed effects univariable and multivariable ordinal logistic regression was used to identify 
significant predictors for the presence of statistical heterogeneity (0%, 1- 29%, 30- 59%, 60- 100%) 
both at review level (including review type, involvement of a statistician, number of syntheses) and 
at synthesis level (including number of studies within syntheses, type of outcome, type of analysis). 
The random effects parameter was the variable study (ie, SR), which represents the between 
cluster variability, as more than one meta-analyses within a SR were considered. Non-significant 
predictors at p= .10 in the univariable analysis were excluded from the multivariable model. The 
presence of significant interaction between type of outcome (binary/ continuous) and type of 
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analysis (random/ fixed effect) was also assessed. The level of statistical significance was pre-
specified at p< 0.05. Statistical analyses were performed with STATA version 15.1 software (Stata 
Corporation, College Station, Tex, USA). 
Results 
A total of 84 systematic reviews including at least one meta-analysis were initially identified, while 
72 remained after applying the eligibility criteria (Figure 1). A quarter of studies were Cochrane 
reviews (n=18, 25%), with 54 being published in orthodontic journals (75%). The majority of the 
reviews were authored by European investigators (45/72, 63%) and were co-authored by 4-6 
researchers (44/72, 61%). Cochrane reviews were more likely to involve a methodologist or 
statistician than non-Cochrane (18/18, 100%, p<0.001), and also to receive funding (16/18, 89%).  
Overall, most reviews included 3 to 5 meta-analyses (n= 24, 33%), while there was a considerable 
increase in the publication of systematic reviews with at least one synthesis in recent years i.e. 
2014- 2017 (n=49, 68%) (Table 1, Figure 2). The mean review heterogeneity (I2%, recorded as the 
average heterogeneity across all syntheses within a review) indicated moderate to considerable I2 
values both within interventional (45/60, 75%) and epidemiologic (10/12, 84%) reviews. A similar 
finding was confirmed for both Cochrane (11/18, 61%) and non-Cochrane reviews (44/54, 81%) 
(Table 2).  
The total of 72 reviews involved 391 syntheses (Table 3); of these, 125 meta-analyses (32%) 
reported absence of heterogeneity or heterogeneity explained by chance (ie, I2= 0%), while 39 
(10%) had I2 values of 1-29%. Higher levels of heterogeneity were identified within 75 (19%) 
syntheses (I2= 30-59%) with 152 (39%) syntheses having I2 ranging from 60-100% (Figure 3). Meta-
analyses including a larger number of studies were more likely to involve higher levels (ie, I2= 60- 
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100%) of heterogeneity (i.e. over 10 studies 21/26, 81%; p<0.001). Likewise, the use of random 
effects analyses for syntheses of individual trial/study estimates were associated with greater I2 
values (~ 60- 100%: 128/278; 46%) (Table 3).  
In the multivariable model, each additional study within individual synthesis was associated with a 
20% increase in the odds for substantial/ considerable heterogeneity (ie, I2= 60- 100%) compared to 
the combined lower heterogeneity categories (OR= 1.20; 95%CIs: 1.09, 1.31; p<0.001). Use of fixed 
effect meta-analyses versus random effects was associated with 75% lower odds for substantial/ 
considerable heterogeneity (I2= 60- 100%) compared to the combined lower heterogeneity values 
categories (OR= 0.25; 95%CIs: 0.12, 0.55; p=0.001). The interaction between type of outcome and 
type of analysis was not significant (Log likelihood ratio test between models with and without 
interaction: p=0.52, Table 4).   
Discussion 
The present meta-epidemiologic report revealed that the majority of meta-analyses presented 
tangible degree of heterogeneity (ie, ≥ 30%). It was interesting that meta-analyses of binary 
outcomes were typically associated with reduced likelihood of considerable heterogeneity and 
increased reporting of absence of heterogeneity or heterogeneity explained by chance (I2= 0%) 
while the opposite trend was observed for syntheses involving continuous outcomes. However, 
meta-analyses of binary outcomes were under-represented in our study and no definite conclusions 
can be drawn. In a similar cross-section of Cochrane and non-Cochrane reviews in medicine, high 
levels of heterogeneity were found to be twice as common in the assessment of continuous rather 
than binary outcomes  [17], with binary outcomes associated with an increased proportion of 
heterogeneity explained by chance [19]. A plausible explanation for this may be related to the fact 
that studies with continuous outcomes may present larger variations in populations, interventions, 
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outcomes and settings or use of more broad eligibility criteria for sample selection thus 
contributing to a substantial dissimilarity in the design and other characteristics and subsequent 
emergence of between-study heterogeneity. An additional assumption might be the fact that 
studies with continuous outcomes may possibly present greater precision of their point estimates 
with more tight confidence intervals, thus contributing to greater between study heterogeneity.   
A greater number of studies included in a synthesis was found to be associated with increased 
likelihood of statistical heterogeneity when compared to fewer studies. This may be partially 
explained by the fact that increasing numbers of studies in a mathematical synthesis, will increase 
spread and heterogeneity of the sample contributing to overall variation. Notwithstanding this, it 
should be recognized that I2 presents low power to detect true statistical heterogeneity when a 
small number of studies are included in a meta-analysis and interpretation of these findings should 
be considered with caution [13,20].  
This is the first attempt to quantify heterogeneity from meta-analyses and identify potential 
predictors based on both review level and synthesis level characteristics in dental research. 
Evaluation was undertaken over a prolonged period with consideration of both Cochrane and non-
Cochrane reviews as these are known to differ in relation to quality and reporting characteristics 
[6]. Consequently, the sample may be regarded as representative of the orthodontic literature 
evidence base. A plethora of previous research has alluded to similar methodological issues 
pertaining to a range of dental specialties suggesting that the results from the present investigation 
are likely to  reflect other areas of dental research [21]. In terms of limitations, assessment of 
heterogeneity within meta-analyses was solely based on reported I2. Although this is an intuitive 
and ubiquitous measure, it does not inform the actual variance of an intervention effect, or the 
between study dispersion of effects [22,23]. Rather it describes the percentage of variability across 
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study effects that can be attributed to heterogeneity rather than chance alone5. Other measures 
such as the use of τau- squared (τ2) are currently available to identify the actual range of effects 
[24,25]. However, these metrics are not widely available within published reports of meta-analyses, 
while their interpretation is not as straightforward as the interpretation of I2. This meta-
epidemiologic study was restricted to review- and syntheses- related characteristics and their 
association with different levels of heterogeneity. The effect of bias-related reporting 
characteristics of studies included in meta-analyses such as blinding, random sequence generation, 
allocation concealment or other reporting related items was not assessed. Although empirical 
evidence from medical research has shown that between-study heterogeneity may be partially 
explained by the reporting of characteristics responsible for bias [26], this was beyond the scope of 
the present work and it may constitute ground for future research.   
Conclusions 
More than one-third of meta-analyses within the orthodontic literature present either substantial 
or considerable statistical heterogeneity (based on I2 values) with increasing heterogeneity 
observed as the number of studies within the syntheses increased. The consistency of meta-
analyses could be improved with more careful consideration of individual study characteristics prior 
to inclusion in a mathematical synthesis ensuring that the quality of the evidence to inform clinical 
practice is enhanced.  
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Legends for illustrations 
Figure 1. Flow diagram of systematic review selection 
Figure 2. Breakdown of orthodontic meta-analyses (%) annually from 2000 to 2017. 
Figure 3. Scatterplot of number of studies within each synthesis and magnitude of statistical heterogeneity 
I2%.  
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Table 1. Distribution of study characteristics by journal type (n=72). 
 
 Non-Cochrane Cochrane Total p-value 
 N (%) N (%)   
Continent    0.10* 
America 6 (85) 1 (15) 7 (100)  
Europe 30 (67) 15 (33) 45 (100)  
Asio/other 18 (90) 2 (10) 20 (100)  
No. of authors    0.26* 
1-3 16 (89) 2 (11) 18 (100)  
4-6 30 (68) 14 (32) 44 (100)  
0ver 6 8 (80) 2 (10) 10 (100)  
Statistician Involved    <0.001* 
No 51 (100) 0 (0) 51 (100)  
Yes 3 (14) 18 (86) 21 (100)  
Year of Publication    0.23* 
2000-2010 10 (63) 6 (37) 16 (100)  
2011-2013 15 (79) 4 (21) 19 (100)  
2014-2017 41 (84) 8 (16) 49 (100)  
Number of syntheses per 
review 
   0.72* 
1 11 (73) 4 (27) 15 (100)  
2 9 (64) 5 (36) 14 (100)  
3-5 19 (79) 5 (21) 24 (100)  
6-10 8 (89) 1 (11) 9 (100)  
Over 10 7 (70) 3 (30) 10 (100)  
Funding    <0.001* 
No 45 (96) 2 (4) 47 (100)  
Yes 9 (36) 16 (64) 25 (100)  
Total 54 (75) 18 (25) 72 (100)  
*Fisher’s exact test 
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Table 2. Distribution of levels of mean heterogeneity based on study type and journal (n=72). 
 
 Mean Heterogeneity I2% Total p-value 
 0 
N (%) 
1-29 
N (%) 
30-59 
N (%) 
60-100 
N (%) 
 
N (%) 
 
Type of study      0.17* 
Interventional 5 (8) 10 (17) 33 (55) 12 (20) 60 (100)  
Epidemiologic 1 (8) 1 (8) 4 (34) 6 (50) 12 (100)  
Journal      0.19* 
Cochrane 2 (11) 5 (28) 6 (33) 5 (28) 18 (100)  
Non-Cochrane 4 (8) 6 (11) 31 (57) 13 (24) 54 (100)  
Total 6 (8) 11 (15) 37 (52) 18 (25) 72 (100)  
* Fisher’s exact test 
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Table 3. Level of heterogeneity according to syntheses variable characteristics (n=391).  
 
 Heterogeneity I2% Total p-value 
 0 
N (%) 
1-29 
N (%) 
30-59 
N (%) 
60-100 
N (%) 
 
N (%) 
 
Number of studies 
within syntheses 
     <0.001 
2 72 (50) 10 (7) 21 (15) 41 (28) 144 (100)  
3-5 44 (25) 23 (13) 37 (21) 71 (41) 175 (100)  
6-10 9 (20) 4 (9) 14 (30) 19 (41) 46 (100)  
0ver 10 0 (0) 2 (8) 3 (11) 21 (81) 26 (100)  
Type of study design 
within synthesis 
     0.98* 
Parallel 114 (31) 38 (10) 72 (20) 142 (39) 366 (100)  
Split-mouth 3 (43) 0 (0) 1 (14) 3 (43) 7 (100)  
Crossover 5 (50) 1 (10) 1 (10) 3 (30) 10 (100)  
Mixed 3 (38) 0 (0) 1 (12) 4 (50) 8 (100)  
Type of analysis      <0.001# 
Random effects 68 (25) 26 (9) 56 (20) 128 (46) 278 (100)  
Fixed effect 57 (50) 13 (12) 19 (17) 24 (21) 113 (100)  
Type of outcome      0.33* 
Continuous 108 (31) 35 (10) 66 (19) 141 (40) 350 (100)  
Binary 17 (41) 4 (10) 9 (22) 11 (27) 41 (100)  
Significance      <0.001* 
No 69 (40) 8 (4) 28 (16) 69 (40) 174 (100)  
Yes 56 (27) 28 (14) 45 (22) 77 (37) 206 (100)  
Non-applicable 0 (0) 3 (27) 2 (18) 6 (55) 11 (100)  
Total 125 (32) 39 (10) 75 (19) 152 (39) 391 (100)  
* Fisher’s exact test, # Pearson chi2 
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Table 4. Mixed effects ordinal logistic regression for the effects of cluster level (review type, type of study, statistician involvement, no. of syntheses per 
study, funding) and individual level (no. of studies within syntheses, type of outcome, type of analysis, significance of outcome) variables on statistical 
heterogeneity (heterogeneity categorized as: 0%, 1- 29%, 30- 59%, 60- 100%). 
 
 Univariable Multivariable 
 Odds Ratio 95%CI p-value Odds Ratio 95%CI p-value 
Cochrane       
No Reference      
Yes 0.55 0.36, 0.86 0.009 2.81 0.53, 14.91 0.22 
Type of study       
Interventional Reference      
Epidemiologic 1.98 0.99, 3.93 0.05 1.47 0.62, 3.47 0.38 
Statistician 
involvement 
      
No Reference      
Yes 0.52 0.35, 0.81 0.003 0.64 0.14, 2.94 0.57 
No. of syntheses       
Per unit 0.98 0.96, 1.00 0.11    
Funding       
No Reference      
Yes 0.86 0.53, 1.39 0.55    
No. of studies within 
syntheses 
      
Per unit 1.23 1.13, 1.33 <0.001 1.20 1.09, 1.31 <0.001 
Type of outcome       
Continuous  Reference   Reference   
Binary 0.55 0.29, 1.06 0.08 0.51 0.23, 1.12 0.09 
Type of analysis       
Random effects Reference   Reference   
19 
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Fixed effect 0.23 0.13, 0.43 <0.001 0.25 0.12, 0.55 0.001 
Type of outcome x type 
of analysis interaction 
     0.52* 
Significance of outcome       
No Reference      
Yes 1.12 0.75, 1.67 0.58    
* Log likelihood ratio test between models with and without interaction 
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Figure 1. 
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Figure 2.  
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Figure 3.  
 
 
